# Scheduled infliximab monotherapy to prevent recurrence of Crohnʼs disease following ileocolic or ileal resection: A 3-year prospective randomized open trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/scheduled-infliximab-monotherapy-to-prevent-recurrence-of-crohn-s-disease/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Kōji Yoshida,Ken Fukunaga,Hiroki Ikeuchi,Koji Kamikozuru,Nobuyuki Hida,Yoshio Ohda,Yoko Yokoyama,Masaki Iimuro,Naohisa Takeda,Kyoichi Kato,Risa Kikuyama,Kazuko Nagase,Kazutoshi Hori,Shirô Nakamura,Hiroto Miwa,Takayuki Matsumoto |
| Citations | 154 |
| DOI | 10.1002/ibd.21928 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://academic.oup.com/ibdjournal/article-pdf/18/9/1617/23420938/ibd1617.pdf |
| OpenAlex ID | https://openalex.org/W2042727833 |
| PMID | 22081474 |
| Type | article |
| Year | 2011 |

## Paper authors

- [Hiroto Miwa](https://scholariq.org/researchers/hiroto-miwa/)
- [Hiroki Ikeuchi](https://scholariq.org/researchers/hiroki-ikeuchi/)
- [Shirô Nakamura](https://scholariq.org/researchers/shiro-nakamura/)

## Paper primary topic

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)

## Paper topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Autoimmune and Inflammatory Disorders](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders/)
- [Celiac Disease Research and Management](https://scholariq.org/topics/celiac-disease-research-and-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.